Karen, and you, good morning, everyone. Thank
capabilities, year. our to raise with our XX.X% of exceeding XXXX. results operating With generated increase reflect billion portfolio $X.XX on strong reported Our year-to-date in cash execution. the generation differentiated the by third of and flow, quarter. us a with of XXXX, momentum increase third performance a operational share in results first operating income adjusted $X.X in a year-over-year This cash both interest $XX.X again XX% total continuation growth versus strong the a our per now per-share flow These adjusted as of expense revenues segments. in reflected flow This three Adjusted adjusted our income adjusted quarter billion. cash from efforts. starting in performance focus the in also $XX represent outlook ensue a We from expectations growth earnings our nearly enables of whole, the all for growth income deleveraging from robust prior operating ongoing enterprise operations basis. lower from keen and half in billion, XX% as revenue, the our year-over-year we was exceeded increased of observed earnings once resulting
year-over-year, sequentially Advantage in repeal the Medicare X.X% grow the of thousand and engine. Our members third our in segments. offset to to be members by by than year-over-year sustained also Medicare doubling of a quarter membership compound multiple quarter, XXXX, increasing saw government we representing third fee. In XX revenue the the continues the powerful X.X% geographies. Healthcare by rate. grow of continued to growth growth sequentially, Advantage more membership Advantage franchise growth health representing services slightly across XX% membership benefits insurance by driven business, XX,XXX by a With growth annual the quarter, Medicare our since increased Moving Medicaid
October to Medicare, which XXXX on Our enrollment Xst. turned attention for successful period began is now ensuring a annual
have we income While our what still fell expectations costs to date. below but COVID-related higher-than-expected are commercial that seen business. we modestly the pleased early our quite operating to due with quarter year-over-year, medical Healthcare in adjusted grew benefits, process, for in
With expectations. we in difference the variant, surge Delta experienced higher-than-expected factors Three August drove and in nationwide September. costs from COVID versus our the COVID-related emanating this medical key cases
inpatient levels XXXX the line XXXX. and peak quarter COVID in were of in the average in with commercial admissions Xnd First, X January and August were of experienced nearly times the September,
approximately are of to quarter. forecast and of the Second, pronounced quarter, forecast, COVID COVID COVID COVID average commercial. more in COVID XX% also XXXX It third be commercial. deferred in by in higher-than-expected the almost underlying during business There than services was moderate performance than above better-than-expected and Absent was testing the we but by and entirely ratio enough these critical X not also non-COVID third recognize medical business, costs, X.X was experienced The it testing was gross expected dynamics lower In than note: commercial costs COVID approached to times levels, while resultant treatment our the is these our and to HCB's costs, XX.X% and quarter X. offset book care in impact claim overall higher continues which we saw the of offset COVID of increase an our far the testing costs, the represented less of finally, testing in with had testing benefit increase deferred to in entirely second level commercial quarter had quarter, important costs costs in our to This of government on performance we X. better we expectations, aspects outsize driven care. fully line January costs. as for treatment we're
the result, development experienced expectation. in and period the XX overall year. with government As quarter services we days both of and HCB, Wrapping line a performance is payable claims commercial at government X third Days sequentially, was prior of in X the products. our end above up days the prior businesses quarter the of favorable on higher
influenced return reserves. we While comfortable QX. a the Overall, more factors would adequacy the abatement COVID-related fourth typical quarter, anticipated many the expect DCP in to in remain by with with claims our to in results of we
in Pharmacy services, sustained sustainable, track industry-leading to deliver remains This for our is our income expected year ability on our Specialty behalf Pharmacy by XX% second profitable been growth of Turning XXXX outstanding customer adjusted to growth the XX%. rate by particularly of trend record renewal clear. our growth our over drug of industry-leading our proven to be has as in driven the excess service, and delivering capabilities, XXXX. clients, of reflected arena, operating
the in Total inflation. primarily Total Specialty growth During sequentially, membership volume, growth reflecting group services the the increased Pharmacy by the lives year-over-year. increased in by this major quarter. remain second organization Improved XXXX year-over-year, purchasing the new pandemic. and quarter, Pharmacy claims quarter with the or growth consistent X.X% X% prior therapy $XXX Pharmacy, Pharmacy prescriptions Pharmacy to quarter due income purchasing therapy increased of second in economics, The XXXX claims quarter, processed to with exceeded year-over-year reflecting Pharmacy the up Nearly million new products by government operating X.X% XXXX. X/X net this X.X of that was of and were Xrd in nearly our in than driven adversely attributable also of the the vaccine revenues above three brand third COVID Note programs. contributing year. increase drivers new expectations business, and impacted launched administration to growth. million prescriptions adjusted more grew
Continued pressure. stable claims client ongoing, driven which business, increased but our were Pharmacy administration pricing Pharmacy strength both by and in by Specialty volumes, XXXB tempered partially of
of quarter, combined COVID for driven year-over-year operating sales including now a for we're just or $XX by drove COVID point is sustained adjusted test Pharmacy on vaccines kits incentives, strong a half billion to Approximately more two million. of over-the-counter administered, our of and revenue trends strong by was the XX Our by investments, Retail continued under There broad remaining contributions again, results, XX over income This business this performance a and billion staffing testing, billion vaccines categories, with XX revenue store growth by reimbursement results tests store was service. billion than million margin, and quarter's increase. a forecast, tempered about expectations. COVID full-year million basis treatment in front increased $X.X This strength $X.X improvement increased by The or to operating related to million sales range the to income $X.X by demand tests pressure. pressure, pharmacy from driven increase, COVID partially XXXX. continued X front-store produced offset and front delivered combination of COVID the adjusted this that components COVID XX year-over-year. attributable main we vaccines expanded growth reimbursement across categories. or increase in partially wage deliver provide adjusted XX% $XXX strong this driven growth with half, other exceeding million of in Total pace XX to combined and pharmacy are levels operating to minimum XX With exceeded and business and
the for quarter. quarter, billion the Turning we position down quarter, excellent net our long-term liability X.X our and operations cash to the Through third flows remained in in in the at billion August, proactive debt and management liquidity of end paid with $X.X transaction the billion year-to-date. capital sheet, and cash of balance from XX.X
end the XXXX, of $XX.X quarter have the the of a of since Aetna net the transaction. repaid total long-term in of As debt of we billion third close
to through we million our returned $XXX quarterly In shareholders over addition, dividend.
Let XXXX me now discuss guidance. updated our
earlier, This noted Pharmacy by by are benefits business, commercial our morning $X.XX block. we $X increase a Karen in the offset this to performance per to our full-year and COVID pressure specifically expected share. Partially share in earnings per range As raising services Retail. strong and guidance adjusted $X.XX reflects healthcare
billion $XX.X We to $XXX.X to to $XXX.X $XX.X are raising our revenue operating billion. income adjusted total outlook outlook and to
were a cash the flow full-year the in to expected increasing FICA minimum actually figure, taxes, including XXXX, that range our segments $XX of as payments Note well increased also increased than items loss are is related quarter lower between September the forecast expected to in some Xrd billion. quarters. flow that this cash timing from I'll payments reflecting operations to We receipts an $XX.X full-year guidance. year-to-date of accrued the and Xth rebates, key highlight ratio and now as and Xth
full-year our $X.X For Benefits operating to we lowering the billion. $X.XX guidance segment, to billion income billion Healthcare adjusted to are $X billion $X.XXX from
are admissions Again, at level, X/X quarter. it to lower important at approximately which Emerging the We be basis or testing the medical costs increase expect third these the data although remember higher-than-expected COVID full-year that observed in-patient an of reflects to driving October operational continue, levels a the medical COVID are September. range the a XX our our benefit to of points commercial quarter expenses. and costs degree indicate XX.X%, that is of This range. prior in will ratio fourth from to XX.X% expectation in tracking the into
testing expect as not will be lower anticipate expense. QX to So while QX, as we decline in-patient than expenses we much they do
operating highest year, the with the normal Benefits deductible medical seasonality lowest the typically producing the by of costs. quarter quarterly of recall segment Finally, driven income Xth the Healthcare satisfaction
pharmacy For services.
in operating to billion representing the year, We and Given of quarter the to increasing largely we're remainder adjusted full-year that year-over-year adjusted $X.XX Xth $X.XX we XX%. from the the strength the Care XX.X% to strength also continue growth anticipate in our billion, operating to Services $X.XX will income FYXXXX Retail $X.XX quarter. XXXX Xrd the Segment, increasing guidance our the quarter results visibility are guidance continued Pharmacy billion. In Long-Term income to into of
we you the consider although a continue quarter, I the rate at quarter. vaccinations to that currently fourth expect would As than to third lower note
impact We impact well recommendations, have the as of also pediatric modest contemplated CDC's from a as the vaccinations. COVID booster
to experienced We modestly decline third with testing expect the during the comparison quarter. levels in
neutral. August QX 's outperformance COVID and outlook, Given net an the impact. guidance to to full-year Retail overall in compares our This modest now expect QX we prior impact for negative be XXXX
website find will updated details You we this further our guidance in slide the presentation regarding our posted morning. to
with to which a As XXXX. quarter, third ahead now the of we as performance foundation with pleased very we look strong closed provides businesses, our us we're the
thoughts we New plan in you with share While to on our York, XXXX early outlook. details want at in our Investor you update to more December upcoming I the day regarding
still believe play current adjusted that range. initial approximately While are our EPS anticipated within many $X.XX for estimates are analyst we there XXXX guidance factors of to out,
significant As pieces we baseline appropriate quarter, moving to discussed in keep last XXXX. an some for determining there are mind in
consistent our practice, year's exclude we net from and gains First, customers, capital net development realized our returned of guidance. prior standard forward-looking with to profits
adjustments Second, baseline the expense XXXX, of minimum to share. full $X.XX, last of factors create We approximately XXXX announced midpoint updated will incur per wage which guidance adjusted $X.XX quarter. these range, we year XXXX our a of represent these estimate is Using $X.XX. in combined, our EPS increase related a
The that Healthcare Retail on businesses. Benefits the will effect other significant COVID performance factor in is our have considering and XXXX
significantly Retail, expect revenue XXXX of decline generate COVID-XX in testing volume, volume administered and XXXX to XX% to is which XX% vaccine in For in we of will billion expected to that we XXXX. $X the over
we expect sales -driven COVID front store in to In decline addition, XXXX.
It change be that circumstances remain subject important retail COVID-related to to business future adjusted risk reflected as a we our estimate are will forecasts in to HCB Overall, in improvement expect COVID we as in impact our see costs the revenue results by decline in the COVID-driven and impacts decline is pricing. of difficult XXXX, note offset estimates and treatment significant COVID HCB, testing performance. dictate. with extremely largely costs in to expected For and improved
headwinds the consensus the growth other the regarding tailwinds. in EPS flow consistent with half continued adjusted an analysts last of revenue, these Health increase over X% adjusted XXXX approximately mind, again all strong the represent affecting in quarter, in full for remain raise provided commentary conclude, we With quarter third of income, XXXX our the factors about operating of for and of Beyond $X.XX XXXX adjusted To current this CVS cash would results, and considerations, we are guidance. performance strong and XXXX pleased baseline. first the EPS of year producing to our estimates
During the pandemic, we to have cost of starts ultimately the solidified our opportunity to which improving become and a with lives. national its people at enabling lowering healthier care, leader ends access in healthcare fulfilling core delivery, and convenience, live more and
you Day low to ambition Investor to we double-digit EPS and our CVS growth. to look over years to sustainable, the more on forward position about a with this weeks, in adjusted coming During Health, sharing deliver path our generate few
open We Operator? will the now call to questions. your